Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Letter
  • Published:

Localization of type 1 diabetes susceptibility to the MHC class I genes HLA-B and HLA-A

Nature volume 450, pages 887–892 (2007)Cite this article

Abstract

The major histocompatibility complex (MHC) on chromosome 6 is associated with susceptibility to more common diseases than any other region of the human genome, including almost all disorders classified as autoimmune. In type 1 diabetes the major genetic susceptibility determinants have been mapped to the MHC class II genes HLA-DQB1 and HLA-DRB1 (refs 1–3), but these genes cannot completely explain the association between type 1 diabetes and the MHC region4,5,6,7,8,9,10,11. Owing to the region’s extreme gene density, the multiplicity of disease-associated alleles, strong associations between alleles, limited genotyping capability, and inadequate statistical approaches and sample sizes, which, and how many, loci within the MHC determine susceptibility remains unclear. Here, in several large type 1 diabetes data sets, we analyse a combined total of 1,729 polymorphisms, and apply statistical methods—recursive partitioning and regression—to pinpoint disease susceptibility to the MHC class I genes HLA-B and HLA-A (risk ratios >1.5; Pcombined = 2.01 × 10-19 and 2.35 × 10-13, respectively) in addition to the established associations of the MHC class II genes. Other loci with smaller and/or rarer effects might also be involved, but to find these, future searches must take into account both the HLA class II and class I genes and use even larger samples. Taken together with previous studies4,5,6,7,8,10,11,12,13,14,15,16 , we conclude that MHC-class-I-mediated events, principally involving HLA-B*39, contribute to the aetiology of type 1 diabetes.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on SpringerLink
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1: Association analyses across the MHC.
Figure 2: Association analyses of 1,475 SNPs across the MHC.

Similar content being viewed by others

References

  1. Todd, J. A., Bell, J. I. & McDevitt, H. O. HLA-DQβ gene contributes to susceptibility and resistance to insulin-dependent diabetes mellitus. Nature 329, 599–604 (1987)

    Article  ADS  CAS  PubMed  Google Scholar 

  2. Cucca, F. et al. A correlation between the relative predisposition of MHC class II alleles to type 1 diabetes and the structure of their proteins. Hum. Mol. Genet. 10, 2025–2037 (2001)

    Article  CAS  PubMed  Google Scholar 

  3. Todd, J. A. et al. Robust associations of four new chromosome regions from genome-wide analyses of type 1 diabetes. Nature Genet. 39, 857–864 (2007)

    Article  CAS  PubMed  Google Scholar 

  4. Fennessy, M. et al. A gene in the HLA class I region contributes to susceptibility to IDDM in the Finnish population. Childhood Diabetes in Finland (DiMe) Study Group. Diabetologia 37, 937–944 (1994)

    Article  CAS  PubMed  Google Scholar 

  5. Nejentsev, S. et al. Non-class II HLA gene associated with type 1 diabetes maps to the 240-kb region near HLA-B. Diabetes 49, 2217–2221 (2000)

    Article  CAS  PubMed  Google Scholar 

  6. Lie, B. A. et al. The predisposition to type 1 diabetes linked to the human leukocyte antigen complex includes at least one non-class II gene. Am. J. Hum. Genet. 64, 793–800 (1999)

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  7. Valdes, A. M. et al. Extended DR3–D6S273-HLA-B haplotypes are associated with increased susceptibility to type 1 diabetes in US Caucasians. Tissue Antigens 65, 115–119 (2005)

    Article  CAS  PubMed  Google Scholar 

  8. Valdes, A. M., Erlich, H. A. & Noble, J. A. Human leukocyte antigen class I B and C loci contribute to Type 1 Diabetes (T1D) susceptibility and age at T1D onset. Hum. Immunol. 66, 301–313 (2005)

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  9. Aly, T. A. et al. Extreme genetic risk for type 1A diabetes. Proc. Natl Acad. Sci. USA 103, 14074–14079 (2006)

    Article  ADS  CAS  PubMed  PubMed Central  Google Scholar 

  10. Noble, J. A. et al. The HLA class I A locus affects susceptibility to type 1 diabetes. Hum. Immunol. 63, 657–664 (2002)

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  11. Honeyman, M. C., Harrison, L. C., Drummond, B., Colman, P. G. & Tait, B. D. Analysis of families at risk for insulin-dependent diabetes mellitus reveals that HLA antigens influence progression to clinical disease. Mol. Med. 1, 576–582 (1995)

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  12. Wicker, L. S. et al. β2-microglobulin-deficient NOD mice do not develop insulitis or diabetes. Diabetes 43, 500–504 (1994)

    Article  CAS  PubMed  Google Scholar 

  13. Utsugi, T. et al. Major histocompatibility complex class I-restricted infiltration and destruction of pancreatic islets by NOD mouse-derived beta-cell cytotoxic CD8+ T-cell clones in vivo . Diabetes 45, 1121–1131 (1996)

    Article  CAS  PubMed  Google Scholar 

  14. Marron, M. P., Graser, R. T., Chapman, H. D. & Serreze, D. V. Functional evidence for the mediation of diabetogenic T cell responses by HLA-A2.1 MHC class I molecules through transgenic expression in NOD mice. Proc. Natl Acad. Sci. USA 99, 13753–13758 (2002)

    Article  ADS  CAS  PubMed  PubMed Central  Google Scholar 

  15. Itoh, N. et al. Mononuclear cell infiltration and its relation to the expression of major histocompatibility complex antigens and adhesion molecules in pancreas biopsy specimens from newly diagnosed insulin-dependent diabetes mellitus patients. J. Clin. Invest. 92, 2313–2322 (1993)

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  16. Foulis, A. K., Liddle, C. N., Farquharson, M. A., Richmond, J. A. & Weir, R. S. The histopathology of the pancreas in type 1 (insulin-dependent) diabetes mellitus: a 25-year review of deaths in patients under 20 years of age in the United Kingdom. Diabetologia 29, 267–274 (1986)

    Article  CAS  PubMed  Google Scholar 

  17. Wellcome Trust Case Control Consortium. Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. Nature 447, 661–678 (2007)

  18. Herr, M. et al. Evaluation of fine mapping strategies for a multifactorial disease locus: systematic linkage and association analysis of IDDM1 in the HLA region on chromosome 6p21. Hum. Mol. Genet. 9, 1291–1301 (2000)

    Article  CAS  PubMed  Google Scholar 

  19. Noble, J. A. et al. The role of HLA class II genes in insulin-dependent diabetes mellitus: molecular analysis of 180 Caucasian, multiplex families. Am. J. Hum. Genet. 59, 1134–1148 (1996)

    CAS  PubMed  PubMed Central  Google Scholar 

  20. Breiman, L., Friedman, J. H., Olshen, R. A. & Stone, C. J. Classification and Regression Trees (Wadsworth, Belmont, 1984)

    MATH  Google Scholar 

  21. R Development Core Team. A Language and Environment for Statistical Computing. (R Foundation for statistical computing, Vienna, 2006)

  22. Therneau, T. M. & Atkinson, E. J. An Introduction to Recursive Partitioning Using the rpart Routine. Technical report no. 61 (Mayo Clinic, section of statistics, Minnesota, 1997)

    Google Scholar 

  23. Roach, J. C. et al. Genetic mapping at 3-kilobase resolution reveals inositol 1,4,5-triphosphate receptor 3 as a risk factor for type 1 diabetes in Sweden. Am. J. Hum. Genet. 79, 614–627 (2006)

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  24. Aly, T. A. et al. High density SNP analysis of the MHC region reveals multiple loci for type 1A diabetes. Clin. Immunol. 123, S133 (2007)

    Article  Google Scholar 

  25. de Jersey, J. et al. Beta cells cannot directly prime diabetogenic CD8 T cells in nonobese diabetic mice. Proc. Natl Acad. Sci. USA 104, 1295–1300 (2007)

    Article  ADS  CAS  PubMed  PubMed Central  Google Scholar 

  26. Poirot, L., Benoist, C. & Mathis, D. Natural killer cells distinguish innocuous and destructive forms of pancreatic islet autoimmunity. Proc. Natl Acad. Sci. USA 101, 8102–8107 (2004)

    Article  ADS  CAS  PubMed  PubMed Central  Google Scholar 

  27. Pinkse, G. G. et al. Autoreactive CD8 T cells associated with beta cell destruction in type 1 diabetes. Proc. Natl Acad. Sci. USA 102, 18425–18430 (2005)

    Article  ADS  CAS  PubMed  PubMed Central  Google Scholar 

  28. Cordell, H. J. & Clayton, D. G. A unified stepwise regression procedure for evaluating the relative effects of polymorphisms within a gene using case/control or family data: application to HLA in type 1 diabetes. Am. J. Hum. Genet. 70, 124–141 (2002)

    Article  CAS  PubMed  Google Scholar 

  29. Stone, M. Cross-validation choice and assessment of statistical predictions. J. R. Stat. Soc. B 36, 111–147 (1974)

    MATH  Google Scholar 

  30. Clayton, D. G. et al. Population structure, differential bias and genomic control in a large-scale, case-control association study. Nature Genet. 37, 1243–1246 (2005)

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgements

This work was funded by the Wellcome Trust and the Juvenile Diabetes Research Foundation International. We thank all of the patients, control subjects and family members for their participation. The Human Biological Data Interchange and Diabetes UK Warren repositories and UK GRID project are acknowledged for the collection of the type 1 diabetes patients and families. We acknowledge use of DNA from the British 1958 birth cohort collection (D. Strachan, S. Ring, W. McArdle, P. Burton, R. Jones and M. Pembrey), funded by the Medical Research Council and Wellcome Trust. S.N. is a Diabetes Research and Wellness Foundation Non-Clinical Fellow. R.D.C. and G.R. were funded by the Medical Research Council.

Author Contributions J.M.M.H performed all statistical data analyses, interpreted results, contributed to the direction of the study and wrote the manuscript. S.N. participated in the conception, design and coordination of the study, genotyping, data analysis and writing of the manuscript. J.A.T. participated in the conception, design and coordination of the study, as well as data analysis and writing of the manuscript. N.M.W. curated the data and helped coordinate the HLA typing. H.E.S. was responsible for DNA. J.S., S.F.F., P.R., M.H., E.K., J.M., J.H., L.M.M., D.S. and R.B. contributed to genotyping of SNPs, microsatellites and HLA loci. J.D.C. provided nsSNP GWA data. G.R. provided SNPs and genotyping in candidate genes from the MHC class III genes. R.D.C. provided SNPs in candidate genes from MHC class III genes. The Wellcome Trust Case Control Consortium provided GWA SNP data. D.G.C. gave guidance on statistical analyses.

Author information

Author notes

  1. Sergey Nejentsev, Joanna M. M. Howson and David Bentley: These authors contributed equally to this work.

Authors and Affiliations

  1. Department of Medical Genetics, Juvenile Diabetes Research Foundation/Wellcome Trust Diabetes and Inflammation Laboratory, Cambridge Institute of Medical Research, University of Cambridge, CB2 0XY, UK

    Sergey Nejentsev, Joanna M. M. Howson, Neil M. Walker, Jeffrey Szeszko, Sarah F. Field, Helen E. Stevens, Pamela Reynolds, Matthew Hardy, Erna King, Jennifer Masters, John Hulme, Lisa M. Maier, Deborah Smyth, Rebecca Bailey, Jason D. Cooper & David G. Clayton

  2. MRC Rosalind Franklin Centre for Genomics Research, Hinxton, Cambridge, CB10 1SB, UK ,

    Gloria Ribas & R. Duncan Campbell

  3. Department of Physiology Anatomy and Genetics, University of Oxford, OX1 3QX, UK

    R. Duncan Campbell

  4. Department of Health Sciences, Genetic Epidemiology Group, University of Leicester, Adrian Building, University Road, Leicester LE1 7RH, UK.,

    Paul R. Burton, Paul R. Burton, Martin D. Tobin, Paul R. Burton, Martin D. Tobin, John R. Thompson, Paul R. Burton & Martin D. Tobin

  5. Department of Medical Genetics, Juvenile Diabetes Research Foundation/Wellcome Trust Diabetes and Inflammation Laboratory, Cambridge Institute for Medical Research, University of Cambridge, Wellcome Trust/MRC Building, Cambridge CB2 0XY, UK.,

    David G. Clayton, John A. Todd, Hin-Tak Leung, David G. Clayton, Sarah Nutland, Helen E. Stevens, Neil M. Walker, John A. Todd, David G. Clayton, David G. Clayton, David B. Dunger, Sarah Nutland, Helen E. Stevens, Neil M. Walker, Barry Widmer, John A. Todd, Kate Downes, Hin-Tak Leung, Sarah Nutland, Helen E. Stevens, Neil M. Walker, John A. Todd, David G. Clayton, David G. Clayton & John A. Todd

  6. Wellcome Trust Centre for Human Genetics, University of Oxford, Roosevelt Drive, Oxford OX3 7BN, UK.,

    Lon R. Cardon, Dominic P. Kwiatkowski, Mark I. McCarthy, Jeffrey C. Barrett, David Evans, Andrew P. Morris, Lon R. Cardon, Kate S. Elliott, Cecilia M. Lindgren, Nigel W. Rayner, Nicholas J. Timpson, Eleftheria Zeggini, Mark I. McCarthy, Emily Lyons, Fredrik Vannberg, Adrian V. S. Hill, Kirk A. Rockett, Dominic P. Kwiatkowski, Jeffrey C. Barrett, David Evans, Andrew P. Morris, Lon R. Cardon, Yik Ying Teo, Lon R. Cardon, Adrian V. S. Hill, Dominic P. Kwiatkowski & Mark I. McCarthy

  7. Department of Psychological Medicine, Henry Wellcome Building, School of Medicine, Cardiff University, Heath Park, Cardiff CF14 4XN, UK.,

    Nick Craddock

  8. The Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridge CB10 1SA, UK.,

    Panos Deloukas, Dominic P. Kwiatkowski, Antony P. Attwood, Dominic P. Kwiatkowski, Claire Bryan, Suzannah J. Bumpstead, Amy Chaney, Kate Downes, Jilur Ghori, Rhian Gwilliam, Sarah E. Hunt, Michael Inouye, Andrew Keniry, Emma King, Ralph McGinnis, Simon Potter, Rathi Ravindrarajah, Pamela Whittaker, David Withers, Panos Deloukas, David Bentley, Panos Deloukas & Dominic P. Kwiatkowski

  9. The Wellcome Trust, Gibbs Building, 215 Euston Road, London NW1 2BE, UK.,

    Audrey Duncanson

  10. Oxford Centre for Diabetes, Endocrinology and Medicine, University of Oxford, Churchill Hospital, Oxford OX3 7LJ, UK.,

    Mark I. McCarthy, Graham A. Hitman, Kate S. Elliott, Christopher J. Groves, Cecilia M. Lindgren, Nigel W. Rayner, Eleftheria Zeggini, Mark I. McCarthy & Mark I. McCarthy

  11. Department of Haematology, University of Cambridge, Long Road, Cambridge CB2 2PT, UK.,

    Willem H. Ouwehand, Antony P. Attwood, James P. Boorman, Barbara Cant, Jennifer D. Jolley, Alexandra S. Knight, Kerstin Koch, Niall C. Taylor, Nicholas A. Watkins, Thilo Winzer, Willem H. Ouwehand & Willem H. Ouwehand

  12. National Health Service Blood and Transplant, Cambridge Centre, Long Road, Cambridge CB2 2PT, UK.,

    Willem H. Ouwehand, James P. Boorman, Nicholas A. Watkins, Willem H. Ouwehand & Willem H. Ouwehand

  13. Department of Cardiovascular Sciences, University of Leicester, Glenfield Hospital, Groby Road, Leicester LE3 9QP, UK.,

    Nilesh J. Samani, Peter S. Braund, Richard J. Dixon, Massimo Mangino, Suzanne Stevens, Nilesh J. Samani, Nilesh J. Samani & Nilesh J. Samani

  14. Department of Statistics, University of Oxford, 1 South Parks Road, Oxford OX1 3TG, UK.,

    Peter Donnelly, Dan Davison, Peter Donnelly, Jonathan L. Marchini, Chris C. A. Spencer, Niall J. Cardin, Dan Davison, Teresa Ferreira, Joanne Pereira-Gale, Ingeleif B. Hallgrimsdóttir, Bryan N. Howie, Jonathan L. Marchini, Chris C. A. Spencer, Zhan Su, Yik Ying Teo, Damjan Vukcevic, Peter Donnelly  & Peter Donnelly

  15. Cancer Research UK Genetic Epidemiology Unit, Strangeways Research Laboratory, Worts Causeway, Cambridge CB1 8RN, UK.,

    Doug Easton & Doug Easton

  16. National Health Service Blood and Transplant, Sheffield Centre, Longley Lane, Sheffield S5 7JN, UK.,

    Ursula Everson

  17. National Health Service Blood and Transplant, Brentwood Centre, Crescent Drive, Brentwood CM15 8DP, UK.,

    Judith M. Hussey

  18. The Welsh Blood Service, Ely Valley Road, Talbot Green, Pontyclun CF72 9WB, UK.,

    Elizabeth Meech

  19. The Scottish National Blood Transfusion Service, Ellen’s Glen Road, Edinburgh EH17 7QT, UK.,

    Christopher V. Prowse

  20. National Health Service Blood and Transplant, Southampton Centre, Coxford Road, Southampton SO16 5AF, UK.,

    Graham R. Walters

  21. Avon Longitudinal Study of Parents and Children, University of Bristol, 24 Tyndall Avenue, Bristol BS8 1TQ, UK.,

    Richard W. Jones, Wendy L. McArdle, Susan M. Ring, Marcus Pembrey & Marcus Pembrey

  22. Division of Community Health Services, St George’s University of London, Cranmer Terrace, London SW17 0RE, UK.,

    David P. Strachan

  23. Institute of Child Health, University College London, 30 Guilford Street, London WC1N 1EH, UK.,

    Marcus Pembrey & Marcus Pembrey

  24. University of Aberdeen, Institute of Medical Sciences, Foresterhill, Aberdeen AB25 2ZD, UK.,

    Gerome Breen & David St Clair

  25. Department of Psychiatry, Division of Neuroscience, Birmingham University, Birmingham B15 2QZ, UK.,

    Sian Caesar, Katherine Gordon-Smith & Lisa Jones

  26. Department of Psychological Medicine, Henry Wellcome Building, School of Medicine, Cardiff University, Heath Park, Cardiff CF14 4XN, UK.,

    Katherine Gordon-Smith, Christine Fraser, Elaine K. Green, Detelina Grozeva, Marian L. Hamshere, Peter A. Holmans, Ian R. Jones, George Kirov, Valentina Moskvina, Ivan Nikolov, Michael C. O’Donovan, Michael J. Owen, Nick Craddock & Nick Craddock

  27. SGDP, The Institute of Psychiatry, King’s College London, De Crespigny Park Denmark Hill, London SE5 8AF, UK.,

    David A. Collier, Amanda Elkin, Anne Farmer, Richard Williamson & Peter McGuffin

  28. School of Neurology, Neurobiology and Psychiatry, Royal Victoria Infirmary, Queen Victoria Road, Newcastle upon Tyne NE1 4LP, UK.,

    Allan H. Young & I. Nicol Ferrier

  29. LIGHT and LIMM Research Institutes, Faculty of Medicine and Health, University of Leeds, Leeds LS1 3EX, UK.,

    Stephen G. Ball, Anthony J. Balmforth, Jennifer H. Barrett, D. Timothy Bishop, Mark M. Iles, Azhar Maqbool, Nadira Yuldasheva, Alistair S. Hall & Alistair S. Hall

  30. IBD Research Group, Addenbrooke’s Hospital, University of Cambridge, Cambridge CB2 2QQ, UK.,

    Francesca Bredin, Mark Tremelling, Miles Parkes & Miles Parkes

  31. Gastrointestinal Unit, School of Molecular and Clinical Medicine, University of Edinburgh, Western General Hospital, Edinburgh EH4 2XU, UK.,

    Hazel Drummond, Charles W. Lees, Elaine R. Nimmo & Jack Satsangi

  32. Department of Medical & Molecular Genetics, King’s College London School of Medicine, 8th Floor Guy’s Tower, Guy’s Hospital, London SE1 9RT, UK.,

    Sheila A. Fisher, Cathryn M. Lewis, Clive M. Onnie, Natalie J. Prescott, Jamie Barbour & Christopher G. Mathew

  33. Institute for Digestive Diseases, University College London Hospitals Trust, London NW1 2BU, UK.,

    Alastair Forbes

  34. Department of Gastroenterology, Guy’s and St Thomas’ NHS Foundation Trust, London SE1 7EH, UK.,

    Jeremy Sanderson

  35. Department of Gastroenterology & Hepatology, University of Newcastle upon Tyne, Royal Victoria Infirmary, Newcastle upon Tyne NE1 4LP, UK.,

    Christopher G. Mathew, M. Khalid Mohiuddin, Catherine E. Todhunter & John C. Mansfield

  36. Gastroenterology Unit, Radcliffe Infirmary, University of Oxford, Oxford OX2 6HE, UK.,

    Tariq Ahmad, Fraser R. Cummings & Derek P. Jewell

  37. Medicine and Therapeutics, Aberdeen Royal Infirmary, Foresterhill, Aberdeen, Grampian AB9 2ZB, UK.,

    John Webster

  38. Clinical Pharmacology Unit and the Diabetes and Inflammation Laboratory, University of Cambridge, Addenbrooke’s Hospital, Hills Road, Cambridge CB2 2QQ, UK.,

    Morris J. Brown

  39. Centre National de Genotypage, 2, Rue Gaston Cremieux, Evry, Paris 91057, France.,

    G. Mark Lathrop

  40. BHF Glasgow Cardiovascular Research Centre, University of Glasgow, 126 University Place, Glasgow G12 8TA, UK.,

    John Connell & Anna Dominiczak

  41. Clinical Pharmacology and Barts and The London Genome Centre, William Harvey Research Institute, Barts and The London, Queen Mary’s School of Medicine, Charterhouse Square, London EC1M 6BQ, UK.,

    Carolina A. Braga, Beverley Burke, Richard Dobson, Johannie Gungadoo, Kate L. Lee, Patricia B. Munroe, Stephen J. Newhouse, Abiodun Onipinla, Chris Wallace, Mingzhan Xue, Mark Caulfield & Mark Caulfield

  42. Cardiovascular Medicine, University of Oxford, Wellcome Trust Centre for Human Genetics, Roosevelt Drive, Oxford OX3 7BN, UK.,

    Martin Farrall & Martin Farrall

  43. arc Epidemiology Research Unit, University of Manchester, Stopford Building, Oxford Road, Manchester M13 9PT, UK.,

    Anne Barton, Ian N. Bruce, Hannah Donovan, Steve Eyre, Paul D. Gilbert, Samantha L. Hider, Anne M. Hinks, Sally L. John, Catherine Potter, Alan J. Silman, Deborah P. M. Symmons, Wendy Thomson, Jane Worthington & Jane Worthington

  44. Department of Paediatrics, University of Cambridge, Addenbrooke’s Hospital, Cambridge CB2 2QQ, UK.,

    David B. Dunger & Barry Widmer

  45. Genetics of Complex Traits, Institute of Biomedical and Clinical Science, Peninsula Medical School, Magdalen Road, Exeter EX1 2LU, UK.,

    Timothy M. Frayling, Rachel M. Freathy, Hana Lango, John R. B. Perry, Michael N. Weedon, Andrew T. Hattersley & Andrew T. Hattersley

  46. Diabetes Genetics, Institute of Biomedical and Clinical Science, Peninsula Medical School, Barrack Road, Exeter EX2 5DU, UK.,

    Timothy M. Frayling, Rachel M. Freathy, Hana Lango, John R. B. Perry, Beverley M. Shields, Michael N. Weedon, Andrew T. Hattersley & Andrew T. Hattersley

  47. Centre for Diabetes and Metabolic Medicine, Barts and The London, Royal London Hospital, Whitechapel, London E1 1BB, UK.,

    Graham A. Hitman

  48. Diabetes Research Group, School of Clinical Medical Sciences, Newcastle University, Framlington Place, Newcastle upon Tyne NE2 4HH, UK.,

    Mark Walker

  49. The MRC Centre for Causal Analyses in Translational Epidemiology, Bristol University, Canynge Hall, Whiteladies Road, Bristol BS2 8PR, UK.,

    Nicholas J. Timpson

  50. MRC Laboratories, Fajara, The Gambia.,

    Melanie Newport, Giorgio Sirugo, David Conway, Muminatou Jallow, Melanie Newport & Giorgio Sirugo

  51. Diamantina Institute for Cancer, Immunology and Metabolic Medicine, Princess Alexandra Hospital, University of Queensland, Woolloongabba, Queensland 4102, Australia.,

    Linda A. Bradbury, Jennifer J. Pointon, Matthew A. Brown & Matthew A. Brown

  52. Botnar Research Centre, University of Oxford, Headington, Oxford OX3 7BN, UK.,

    Claire Farrar, Paul Wordsworth, Matthew A. Brown & Matthew A. Brown

  53. Department of Medicine, Division of Medical Sciences, Institute of Biomedical Research, University of Birmingham, Edgbaston, Birmingham B15 2TT, UK.,

    Jayne A. Franklyn, Joanne M. Heward, Matthew J. Simmonds, Stephen C. L. Gough & Stephen C. L. Gough

  54. Section of Cancer Genetics, Institute of Cancer Research, 15 Cotswold Road, Sutton SM2 5NG, UK.,

    Sheila Seal, Michael R. Stratton, Nazneen Rahman, Nazneen Rahman & Michael R. Stratton

  55. Cancer Genome Project, The Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridge CB10 1SA, UK.,

    Michael R. Stratton & Michael R. Stratton

  56. Lists of participants and affiliations appear at the end of the paper.,

    David Bentley

Authors
  1. Sergey Nejentsev
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Joanna M. M. Howson
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Neil M. Walker
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Jeffrey Szeszko
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Sarah F. Field
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Helen E. Stevens
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Pamela Reynolds
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Matthew Hardy
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Erna King
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Jennifer Masters
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. John Hulme
    View author publications

    You can also search for this author in PubMed Google Scholar

  12. Lisa M. Maier
    View author publications

    You can also search for this author in PubMed Google Scholar

  13. Deborah Smyth
    View author publications

    You can also search for this author in PubMed Google Scholar

  14. Rebecca Bailey
    View author publications

    You can also search for this author in PubMed Google Scholar

  15. Jason D. Cooper
    View author publications

    You can also search for this author in PubMed Google Scholar

  16. Gloria Ribas
    View author publications

    You can also search for this author in PubMed Google Scholar

  17. R. Duncan Campbell
    View author publications

    You can also search for this author in PubMed Google Scholar

  18. David G. Clayton
    View author publications

    You can also search for this author in PubMed Google Scholar

  19. John A. Todd
    View author publications

    You can also search for this author in PubMed Google Scholar

Consortia

The Wellcome Trust Case Control Consortium

  • Management committee

    • Paul R. Burton
    • , David G. Clayton
    • , Lon R. Cardon
    • , Nick Craddock
    • , Panos Deloukas
    • , Audrey Duncanson
    • , Dominic P. Kwiatkowski
    • , Mark I. McCarthy
    • , Willem H. Ouwehand
    • , Nilesh J. Samani
    • , John A. Todd
    •  & Peter Donnelly

  • Analysis committee

    • Jeffrey C. Barrett
    • , Paul R. Burton
    • , Dan Davison
    • , Peter Donnelly
    • , Doug Easton
    • , David Evans
    • , Hin-Tak Leung
    • , Jonathan L. Marchini
    • , Andrew P. Morris
    • , Chris C. A. Spencer
    • , Martin D. Tobin
    • , Lon R. Cardon
    •  & David G. Clayton

  • UK blood services and University of Cambridge controls

    • Antony P. Attwood
    • , James P. Boorman
    • , Barbara Cant
    • , Ursula Everson
    • , Judith M. Hussey
    • , Jennifer D. Jolley
    • , Alexandra S. Knight
    • , Kerstin Koch
    • , Elizabeth Meech
    • , Sarah Nutland
    • , Christopher V. Prowse
    • , Helen E. Stevens
    • , Niall C. Taylor
    • , Graham R. Walters
    • , Neil M. Walker
    • , Nicholas A. Watkins
    • , Thilo Winzer
    • , John A. Todd
    •  & Willem H. Ouwehand

  • 1958 birth cohort controls

    • Richard W. Jones
    • , Wendy L. McArdle
    • , Susan M. Ring
    • , David P. Strachan
    •  & Marcus Pembrey

  • Bipolar disorder

    • Gerome Breen
    • , David St Clair
    • , Sian Caesar
    • , Katherine Gordon-Smith
    • , Lisa Jones
    • , Christine Fraser
    • , Elaine K. Green
    • , Detelina Grozeva
    • , Marian L. Hamshere
    • , Peter A. Holmans
    • , Ian R. Jones
    • , George Kirov
    • , Valentina Moskvina
    • , Ivan Nikolov
    • , Michael C. O’Donovan
    • , Michael J. Owen
    • , Nick Craddock
    • , David A. Collier
    • , Amanda Elkin
    • , Anne Farmer
    • , Richard Williamson
    • , Peter McGuffin
    • , Allan H. Young
    •  & I. Nicol Ferrier

  • Coronary artery disease

    • Stephen G. Ball
    • , Anthony J. Balmforth
    • , Jennifer H. Barrett
    • , D. Timothy Bishop
    • , Mark M. Iles
    • , Azhar Maqbool
    • , Nadira Yuldasheva
    • , Alistair S. Hall
    • , Peter S. Braund
    • , Paul R. Burton
    • , Richard J. Dixon
    • , Massimo Mangino
    • , Suzanne Stevens
    • , Martin D. Tobin
    • , John R. Thompson
    •  & Nilesh J. Samani

  • Crohn’s disease

    • Francesca Bredin
    • , Mark Tremelling
    • , Miles Parkes
    • , Hazel Drummond
    • , Charles W. Lees
    • , Elaine R. Nimmo
    • , Jack Satsangi
    • , Sheila A. Fisher
    • , Alastair Forbes
    • , Cathryn M. Lewis
    • , Clive M. Onnie
    • , Natalie J. Prescott
    • , Jeremy Sanderson
    • , Christopher G. Mathew
    • , Jamie Barbour
    • , M. Khalid Mohiuddin
    • , Catherine E. Todhunter
    • , John C. Mansfield
    • , Tariq Ahmad
    • , Fraser R. Cummings
    •  & Derek P. Jewell

  • Hypertension

    • John Webster
    • , Morris J. Brown
    • , David G. Clayton
    • , G. Mark Lathrop
    • , John Connell
    • , Anna Dominiczak
    • , Nilesh J. Samani
    • , Carolina A. Braga
    • , Beverley Burke
    • , Richard Dobson
    • , Johannie Gungadoo
    • , Kate L. Lee
    • , Patricia B. Munroe
    • , Stephen J. Newhouse
    • , Abiodun Onipinla
    • , Chris Wallace
    • , Mingzhan Xue
    • , Mark Caulfield
    •  & Martin Farrall

  • Rheumatoid arthritis

    • Anne Barton
    • , The Biologics in RA Genetics and Genomics Study Syndicate (BRAGGS) Steering Committee
    • , Ian N. Bruce
    • , Hannah Donovan
    • , Steve Eyre
    • , Paul D. Gilbert
    • , Samantha L. Hider
    • , Anne M. Hinks
    • , Sally L. John
    • , Catherine Potter
    • , Alan J. Silman
    • , Deborah P. M. Symmons
    • , Wendy Thomson
    •  & Jane Worthington

  • Type 1 diabetes

    • David G. Clayton
    • , David B. Dunger
    • , Sarah Nutland
    • , Helen E. Stevens
    • , Neil M. Walker
    • , Barry Widmer
    •  & John A. Todd

  • Type 2 diabetes

    • Timothy M. Frayling
    • , Rachel M. Freathy
    • , Hana Lango
    • , John R. B. Perry
    • , Beverley M. Shields
    • , Michael N. Weedon
    • , Andrew T. Hattersley
    • , Graham A. Hitman
    • , Mark Walker
    • , Kate S. Elliott
    • , Christopher J. Groves
    • , Cecilia M. Lindgren
    • , Nigel W. Rayner
    • , Nicholas J. Timpson
    • , Eleftheria Zeggini
    •  & Mark I. McCarthy

  • Tuberculosis

    • Melanie Newport
    • , Giorgio Sirugo
    • , Emily Lyons
    • , Fredrik Vannberg
    •  & Adrian V. S. Hill

  • Ankylosing spondylitis

    • Linda A. Bradbury
    • , Claire Farrar
    • , Jennifer J. Pointon
    • , Paul Wordsworth
    •  & Matthew A. Brown

  • Autoimmune thyroid disease

    • Jayne A. Franklyn
    • , Joanne M. Heward
    • , Matthew J. Simmonds
    •  & Stephen C. L. Gough

  • Breast cancer

    • Sheila Seal
    • , Breast Cancer Susceptibility Collaboration (UK)
    • , Michael R. Stratton
    •  & Nazneen Rahman

  • Multiple sclerosis

    • Maria Ban
    • , An Goris
    • , Stephen J. Sawcer
    •  & Alastair Compston

  • Gambian controls

    • David Conway
    • , Muminatou Jallow
    • , Melanie Newport
    • , Giorgio Sirugo
    • , Kirk A. Rockett
    •  & Dominic P. Kwiatkowski

  • DNA, genotyping, data QC and informatics

    • Claire Bryan
    • , Suzannah J. Bumpstead
    • , Amy Chaney
    • , Kate Downes
    • , Jilur Ghori
    • , Rhian Gwilliam
    • , Sarah E. Hunt
    • , Michael Inouye
    • , Andrew Keniry
    • , Emma King
    • , Ralph McGinnis
    • , Simon Potter
    • , Rathi Ravindrarajah
    • , Pamela Whittaker
    • , David Withers
    • , Panos Deloukas
    • , Hin-Tak Leung
    • , Sarah Nutland
    • , Helen E. Stevens
    • , Neil M. Walker
    •  & John A. Todd

  • Statistics

    • Doug Easton
    • , David G. Clayton
    • , Paul R. Burton
    • , Martin D. Tobin
    • , Jeffrey C. Barrett
    • , David Evans
    • , Andrew P. Morris
    • , Lon R. Cardon
    • , Niall J. Cardin
    • , Dan Davison
    • , Teresa Ferreira
    • , Joanne Pereira-Gale
    • , Ingeleif B. Hallgrimsdóttir
    • , Bryan N. Howie
    • , Jonathan L. Marchini
    • , Chris C. A. Spencer
    • , Zhan Su
    • , Yik Ying Teo
    • , Damjan Vukcevic
    •  & Peter Donnelly

  • Primary investigators

    • David Bentley
    • , Matthew A. Brown
    • , Lon R. Cardon
    • , Mark Caulfield
    • , David G. Clayton
    • , Alistair Compston
    • , Nick Craddock
    • , Panos Deloukas
    • , Peter Donnelly
    • , Martin Farrall
    • , Stephen C. L. Gough
    • , Alistair S. Hall
    • , Andrew T. Hattersley
    • , Adrian V. S. Hill
    • , Dominic P. Kwiatkowski
    • , Christopher G. Mathew
    • , Mark I. McCarthy
    • , Willem H. Ouwehand
    • , Miles Parkes
    • , Marcus Pembrey
    • , Nazneen Rahman
    • , Nilesh J. Samani
    • , Michael R. Stratton
    • , John A. Todd
    •  & Jane Worthington

Corresponding author

Correspondence to Joanna M. M. Howson.

Ethics declarations

Competing interests

The authors declare no competing financial interests.

Supplementary information

Supplementary Information 1

The file contains Supplementary Results, Supplementary Discussion, Supplementary Methods, Supplementary Tables 1-7 and Supplementary Figure 1 with Legends (PDF 455 kb)

Supplementary Information 2

The file contains the list of members of The Biologics in RA Genetics and Genomics Study Syndicate (BRAGGS) Steering Committee and Breast Cancer Susceptibility Collaboration (UK) (PDF 33 kb)

Rights and permissions

Reprints and permissions

About this article

Cite this article

Nejentsev, S., Howson, J., Walker, N. et al. Localization of type 1 diabetes susceptibility to the MHC class I genes HLA-B and HLA-A. Nature 450, 887–892 (2007). https://doi.org/10.1038/nature06406

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nature06406

This article is cited by

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing